Pharmafile Logo
Pharmafocus logo
Advanced Search
ASCO 2011

ASCO 2011: news from the front line against cancer

July 18, 2011
Research and Development ASCO, Cancer, oncology

Pharmafocus presents selected highlights from the American Society of Clinical Oncology’s annual meeting in Chicago, beginning with non-small cell lung …

Feature

NICE decides laser treatment better than Lucentis

July 18, 2011
Sales and Marketing Lucentis, NICE, Novartis

Novartis says it is “disappointed” with health watchdog NICE’s decision not to recommend Lucentis for the treatment of eye problems …

News

Amgen bone cancer drug Xgeva approved in Europe

July 18, 2011
Sales and Marketing Amgen, Prolia, Xgeva, denosumab

Amgen’s bone cancer drug Xgeva (denosumab) has been approved in Europe to prevent serious bone problems in cancer patients. Already …

News
GlaxoSmithKline

GSK downsizes Irish OTC plant

July 18, 2011
Manufacturing and Production GSK, Ireland, pharma manufacturing news

GlaxoSmithKline is cutting around 130 jobs at a facility in Waterford, Ireland, over the next three years as part of …

News

Pharma manufacturing news in brief

July 18, 2011
Manufacturing and Production pharma manufacturing news

Our round-up of news in the pharmaceutical manufacturing sector includes facility updates from NanoSonic, Tianyin Pharma, Orchid and Boehringer Ingelheim, …

News
Novartis Kick Smoking iPhone app

Digital Pharma: iPhone and iPad app update

July 15, 2011
Medical Communications, Sales and Marketing Blackberry, Digital Pharma blog, ipad, iphone, mobile

How many iPads has Boehringer Ingelheim ordered for its sales force in Turkey? Do Novartis’ investors really want their annual …

News

Lophius Biosciences expands management team

July 15, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

German biotech Lophius Biosciences has made six senior management appointments ahead of a planned 2012 market entry move. The Regensburg-based …

Appointment

Reynolds-MacKenzie joins Open Health

July 15, 2011
Medical Communications medical communications agency, medical communications news

Specialist health agency Reynolds-MacKenzie has become the latest recruit to the Open Health stable, bolstering the new communications group’s PR …

News

The changing fortunes of NICE and health secretaries

July 15, 2011
Sales and Marketing NICE

You might not have noticed, but the government has performed a major U-turn. No, I don’t mean the NHS reform …

Feature

UK pricing reform derailed

July 15, 2011
Sales and Marketing NICE, PPRS, value-based pricing

Plans to revolutionise the pricing of medicines in the UK look to be another casualty in the Department of Health’s …

News
Doctors and social media

Digital Pharma: Facebook warning for UK doctors

July 14, 2011
Medical Communications BMA, Digital Pharma blog, doctors, nurses, social media

UK doctors have been told not to accept patients as Facebook friends in order to maintain professional boundaries. The BMA’s …

News

European approval for BMS skin cancer vaccine

July 14, 2011
Sales and Marketing BMS, Yervoy, ipilimumab

Bristol-Myers Squibb’s skin cancer vaccine Yervoy has been approved in Europe after showing survival benefits in one of the most …

News

France cleans up regulation – and restricts pharma role

July 14, 2011
Research and Development, Sales and Marketing France, Mediator, Servier, pharmacovigilance, research and development news

France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …

News

Spain’s austerity sees pharma market shrink by €2 billion

July 14, 2011
Sales and Marketing Spain, healthcare costs

Spain’s pharma industry has hit out against the drastic budget cuts the government introduced last year, saying they’ve led to …

News

Market access and the new consortia

July 14, 2011
Sales and Marketing GP consortia, NHS reform, market access

The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …

Feature

Paul Barrow joins CiToxLAB

July 14, 2011
Research and Development appointment, research and development

French CRO CiToxLAB has appointed Paul Barrow as director of scientific projects and client consulting. He joins the Evreux-based company, …

Appointment
Newcastle GP consortia

What now for GP consortia?

July 13, 2011
Sales and Marketing GP consortia, NHS reforms

David Cameron unveiled major changes to the direction of the health reforms on 8 June – and in doing so, …

Feature

Sanofi eyes phase III move for sarilumab in rheumatoid arthritis

July 13, 2011
Research and Development Regeneron, Sanofi, ankylosing spondylitis, research and development news, rheumatoid arthritis, sarilumab

Sanofi is poised to move sarilumab into phase III trials for rheumatoid arthritis after the monoclonal antibody showed positive results …

News
US Food and Drug Administration

Pharma regulators consult on drug development initiatives

July 13, 2011
Research and Development Companion Diagnostics, EMA, FDA, Pharmacogenomics, biomarkers, research and development news

Pharma regulators in the US and Europe have put out separate consultations on issues affecting how medicines are developed. The …

News
Amgen

Amgen collaborates on cancer antibody research

July 13, 2011
Research and Development Amgen, Cancer, TGF-beta monoclonal antibody, research and development news

Amgen has teamed up with German biotech Micromet to develop tumour-destroying antibodies in a two-year deal that could net Micromet …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026